Objective To evaluate whether body size in early life has an independent effect on risk of
disease in later life or whether its influence is mediated by body size in adulthood. Design Two …

Characterizing genetic influences on DNA methylation (DNAm) provides an opportunity to
understand mechanisms underpinning gene regulation and disease. In the present study, we …

The human proteome is a major source of therapeutic targets. Recent genetic association
analyses of the plasma proteome enable systematic evaluation of the causal consequences of …

Background Circulating lipoprotein lipids cause coronary heart disease (CHD). However,
the precise way in which one or more lipoprotein lipid-related entities account for this …

The Pharma Proteomics Project is a precompetitive biopharmaceutical consortium characterizing
the plasma proteomic profiles of 54,219 UK Biobank participants. Here we provide a …

In this trans-ethnic multi-omic study, we reinterpret the genetic architecture of blood
pressure to identify genes, tissues, phenomes and medication contexts of blood pressure …

Large-scale molecular profiling and genotyping provide a unique opportunity to systematically
compare the genetically predicted effects of therapeutic targets on the human metabolome…

Background and Aims We hypothesized that a genetic risk score (GRS) for fatty liver disease
influences the risk of cirrhosis and hepatocellular carcinoma (HCC). Three genetic variants (…

Background Biological aging estimators derived from DNA methylation data are heritable
and correlate with morbidity and mortality. Consequently, identification of genetic and …

10.7554/eLife.43657.001 The age of large-scale genome-wide association studies (GWAS)
has provided us with an unprecedented opportunity to evaluate the genetic liability of …